¼¼°èÀÇ Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀå
Artificial Tendons and Ligaments
»óǰÄÚµå : 1768184
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 279 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,225,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,675,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Àΰø°Ç ¹× ÀΰøÀÎ´ë ¼¼°è ½ÃÀåÀº 2030³â±îÁö 7,510¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 4,100¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â Àΰø°Ç ¹× ÀΰøÀÎ´ë ¼¼°è ½ÃÀåÀº 2024-2030³â ºÐ¼® ±â°£ µ¿¾È CAGR 10.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 7,510¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ½½°üÀý ¼Õ»óÀº CAGR 11.0%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 3,520¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹ß°ú ¹ß¸ñ »óÇØ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 10.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 1,050¸¸ ´Þ·¯, Áß±¹Àº CAGR 14.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀåÀº 2024³â¿¡ 1,050¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ 2024³âºÎÅÍ 2030³â±îÁö CAGR 14.1%¸¦ ´õµë¾î, 2030³â¿¡´Â 1,740¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 7.1%¿Í 8.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 8.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Àΰø°Ç ¹× ÀΰøÀδë´Â Á¤Çü¿Ü°ú ÀÇ·áÀÇ ¹Ì·¡Àΰ¡?

Àΰø°Ç ¹× ÀΰøÀδë´Â Á¤Çü¿Ü°ú ÀÇ·á¿¡ º¯È­¸¦ °¡Á®¿ÔÀ¸¸ç, ÀÎ´ë ¼Õ»ó ¹× ÅðÇ༺ ÁúȯÀ¸·Î °íÅë¹Þ´Â »ç¶÷µé¿¡°Ô ȹ±âÀûÀÎ ÁøÀüÀ» ¾à¼ÓÇÕ´Ï´Ù. ±âÁ¸¿¡´Â ¼Õ»óµÈ ÈûÁÙ°ú Àδ븦 ȯÀÚ ÀÚ½ÅÀÇ ½Åü ¶Ç´Â ±âÁõÀÚÀÇ ÀÌ½ÄÆíÀ¸·Î Ä¡·áÇßÁö¸¸, ÀÌ Ä¡·á¹ýÀº °á°ú°¡ ´Ù¾çÇϰí, ¸é¿ª ¹ÝÀÀÀÌ ÀϾ±â ½¬¿ì¸ç, ȸº¹¿¡ ½Ã°£ÀÌ ¿À·¡ °É¸°´Ù´Â ´ÜÁ¡ÀÌ ÀÖ¾ú½À´Ï´Ù. ÇÕ¼º ÈûÁÙ°ú ÀδëÀÇ µµÀÔÀº ±âÁõÀÚ Á¶Á÷¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ÁÙÀÌ°í »ý¹°ÇÐÀû ÀÌ½ÄÆí°ú °ü·ÃµÈ ÇÕº´ÁõÀ» ÃÖ¼ÒÈ­ÇÏ´Â ½Å·ÚÇÒ ¼ö ÀÖ´Â ´ë¾ÈÀ» Á¦°øÇÕ´Ï´Ù. Æú¸®¿¡Æ¿·» Å×·¹ÇÁÅ»·¹ÀÌÆ®(PET), Æú¸®¶ôÆ®»ê(PLA), Æú¸®¿ì·¹Åº°ú °°Àº »ýüÀûÇÕ¼º Àç·á·Î ¸¸µé¾îÁø Àΰø°Ç ¹× ÀΰøÀδë´Â ÀÎü Á¶Á÷ÀÇ ÀÚ¿¬Àû Ư¼ºÀ» ¸ð¹æÇϵµ·Ï ¼³°èÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ÒÀç´Â ȯÀÚÀÇ ÇØºÎÇÐÀû ±¸Á¶¿¡ Á¤È®ÇÏ°Ô ¸Âµµ·Ï ¸ÂÃã Á¦ÀÛÇÒ ¼ö ÀÖ¾î °ÅºÎ¹ÝÀÀÀÇ À§ÇèÀ» Å©°Ô ÁÙÀ̰í Àå±âÀûÀÎ ¼º´ÉÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ´õ ¸¹Àº Á¤Çü¿Ü°ú Àü¹®°¡µéÀÌ ÇÕ¼º ´ëüÀçÀÇ °¡Ä¡¸¦ ÀνÄÇÔ¿¡ µû¶ó Àΰø°Ç ¹× ÀΰøÀδë´Â ź·Â¼º, ³»±¸¼º ¹× ÀÎÀå °­µµ·Î ÀÎÇØ Á¡Á¡ ´õ ¸¹Àº ÀÓ»ó Àû¿ëÀÌ Çã¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àΰø ±¸Á¶¹°ÀÇ ÁøÈ­´Â ½ºÆ÷Ã÷ ºÎ»ó°ú ÅðÇ༺ °üÀý Áúȯ ¸ðµÎ¿¡ ´ëÀÀÇÏ¿© ÷´Ü Á¤Çü¿Ü°ú ÀÇ·á¿¡¼­ ¸Å¿ì À¯¸ÁÇÑ ¿É¼ÇÀ¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº Àΰø°Ç ¹× ÀΰøÀδëÀÇ ¹ßÀüÀ» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº Àΰø°Ç ¹× ÀΰøÀÎ´ë °³¹ß ºÐ¾ß¸¦ Å©°Ô Çü¼ºÇϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ÇÕ¼º ¼Ö·ç¼ÇÀÇ ¹°¸®Àû Ư¼º°ú ±â´ÉÀû È¿À²¼ºÀ» ¸ðµÎ Çâ»ó½ÃŰ´Â ±â¼ú Çõ½ÅÀ¸·Î À̾îÁ³½À´Ï´Ù. Àç·á °úÇÐÀÇ ¹ßÀüÀ¸·Î Àΰø°Ç ¹× ÀΰøÀδë´Â õ¿¬ Á¶Á÷ÀÇ ±¸Á¶Àû ¹× ±â°èÀû Ư¼ºÀ» Ãæ½ÇÈ÷ ¸ð¹æÇϰí ÀÎü¿¡ ¿Ïº®ÇÏ°Ô ¸Âµµ·Ï ¸¸µé¾îÁ³½À´Ï´Ù. ¿¬±¸¸¦ ÅëÇØ Æú¸®¿ì·¹Åº º¹ÇÕÀç¿Í ¾Æ¶ó¹Ìµå ¼¶À¯¿Í °°Àº ½Å¼ÒÀç°¡ µµÀÔµÇ¾î ³»±¸¼º°ú À¯¿¬¼ºÀÌ Çâ»óµÇ°í Àå±âÀûÀÎ »ýü¿ªÇÐÀû ½ºÆ®·¹½º¸¦ °ßµô ¼ö ÀÖ´Â Àΰø°üÀýÀÌ È¯ÀÚ¿¡°Ô Á¦°øµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, 3D ÇÁ¸°ÆÃ ±â¼úÀº °¢ °³ÀÎÀÇ °íÀ¯ÇÑ ÇØºÎÇÐÀû ±¸Á¶¿¡ ¸Â°Ô Á¶Á¤µÈ ȯÀÚ ¸ÂÃãÇü ÀÌ½ÄÆíÀ» Á¦ÀÛÇÒ ¼ö ÀÖ°ÔÇÔÀ¸·Î½á ÀÚ¿¬½º·¯¿î °üÀý ¿òÁ÷ÀÓ¿¡ ´ëÇÑ ÀûÇÕ¼º°ú ÀûÀÀ¼ºÀ» ÃÖÀûÈ­ÇÏ¿© Á¦Á¶ °øÁ¤¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×½À´Ï´Ù. ¶Ç ´Ù¸¥ ±â¼úÀû µµ¾àÀº ³ª³ë±â¼ú ºÐ¾ß¿¡¼­ ÀÌ·ç¾îÁ³½À´Ï´Ù. ³ª³ë±â¼úÀº ÀÌ·¯ÇÑ Àΰø ÀδëÀÇ ¼¼Æ÷ °£ »óÈ£ÀÛ¿ë°ú Ç¥¸é Ư¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ³ª³ë±â¼ú·Î °­È­µÈ Ç¥¸éÀº ÀÚ¿¬½º·¯¿î Á¶Á÷ ÅëÇÕÀ» ÃËÁøÇÏ´Â µ¿½Ã¿¡ ¿°ÁõÀÇ À§ÇèÀ» ÁÙÀÔ´Ï´Ù. ¶ÇÇÑ, »ýºÐÇØ¼º ¹× »ýüÈí¼ö¼º ¼ÒÀç°¡ ½ÃÀå¿¡ Ãâ½ÃµÇ¾î ½Ã°£ÀÌ Áö³²¿¡ µû¶ó ÀÚ¿¬ÀûÀ¸·Î ¿ëÇØµÇ´Â ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á Ãß°¡ÀûÀÎ ¼ö¼úÀû Á¦°ÅÀÇ Çʿ伺À» ¾ø¾Ö°í Àå±âÀûÀÎ Ä¡À¯¿¡ ´ëÇÑ Áö¼Ó°¡´ÉÇÑ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

Àΰø°Ç ¹× ÀΰøÀδ밡 ȯÀÚ¿Í ¿Ü°ú ÀÇ»çµé »çÀÌ¿¡¼­ Àα⸦ ¾ò°í ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

Àΰø°Ç ¹× ÀΰøÀδë´Â ±âÁ¸ÀÇ »ý¹°ÇÐÀû ÀÌ½ÄÆí¿¡ ºñÇØ ȸº¹ÀÌ ºü¸£°í, ÇÕº´ÁõÀÌ ÀûÀ¸¸ç, ħ½À¼ºÀÌ ³·¾Æ ȯÀÚ¿Í ¿Ü°úÀÇ»çµé »çÀÌ¿¡¼­ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ȯÀÚ, ƯÈ÷ ¿îµ¿¼±¼ö³ª Ȱµ¿ÀûÀÎ »ýȰÀ» ÇÏ´Â »ç¶÷µé¿¡°Ô Àΰø°üÀýÀº ºü¸¥ ȸº¹À» À§ÇÑ Áö¸§±æÀ̸ç, ÀÌ·¯ÇÑ Àΰø°üÀýÀ» »ç¿ëÇÏ¸é ½ÅüÀÇ ´Ù¸¥ ºÎÀ§¿¡¼­ ±âÁõÀÚ Á¶Á÷À» äÃëÇÏ´Â 2Â÷ ¼ö¼úÀÌ ÇÊ¿äÇÏÁö ¾Ê¾Æ ÀÌÂ÷ ¼ö¼úÀÇ ÀÌȯÀ²À» ³·Ãâ ¼ö ÀÖ½À´Ï´Ù. ½ºÆ÷Ã÷¿¡¼­ ÈçÈ÷ º¼ ¼ö ÀÖ´Â ACLÀ̳ª MCL ÆÄ¿­°ú °°Àº ÀÎ´ë ¼Õ»óÀ¸·Î °í»ýÇÏ´Â »ç¶÷µéÀº ÀÌ·¯ÇÑ ÀåÁ¡ ¶§¹®¿¡ Àΰø°üÀý ġȯ¼úÀ» ¼±ÅÃÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¸¶Âù°¡Áö·Î, Àΰø°üÀý ġȯ¼úÀº °üÀýÀÇ ÅðÇàÀ» °æÇèÇÏ´Â °æ¿ì°¡ ¸¹°í, º¹ÀâÇϰí Àå±â°£¿¡ °ÉÄ£ »ýü ÀÌ½Ä ¼ö¼úÀÇ ´ë¾ÈÀ» ã´Â ³ëÀÎµé »çÀÌ¿¡¼­ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¿Ü°ú ÀÇ»çÀÇ ÀÔÀå¿¡¼­ ÇÕ¼º ¿É¼ÇÀº ¼ö¼ú ½Ã°£°ú º¹À⼺À» ÁÙ¿© ¼ö¼ú ½Ã°£À» ´ÜÃàÇÏ°í ¼ö¼ú ½Ã°£À» ´ÜÃàÇϰí ÀÔ¿ø ±â°£À» ´ÜÃàÇÏ¿© ºñ¿ë È¿À²ÀûÀ̰í ȯÀÚÀÇ ÀçȰÀ» °¡¼ÓÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àΰø°Ç ¹× ÀΰøÀδë´Â ¶ÇÇÑ »ý¹°ÇÐÀû ÀÌ½ÄÆí¿¡¼­ ÈçÈ÷ ¿ì·ÁµÇ´Â ¸é¿ª ¹ÝÀÀÀÇ °¡´É¼ºÀ» ³·Ãß°í, ¿©·¯ ¼ö¼ú ºÎÀ§ÀÇ Çʿ伺À» ÇÇÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç, À§ÇèÀ» ÃÖ¼ÒÈ­Çϰí ȯÀÚÀÇ Æí¾ÈÇÔÀ» ±Ø´ëÈ­ÇÏ´Â ÃÖ¼Òħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö´Â Ãß¼¼¿¡ Àß ºÎÇÕÇÕ´Ï´Ù.

Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, ÃÖÁ¾ ¿ëµµÀÇ ÁøÈ­, ȯÀÚ Çൿ ¹× ±â´ëÄ¡ÀÇ º¯È­ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀº AI¿Í ¸Ó½Å·¯´×À» µµÀÔÇÏ¿© °¢ ȯÀÚÀÇ °íÀ¯ÇÑ ÇØºÎÇÐÀû ±¸Á¶¿Í »ýü¿ªÇп¡ ¸Â°Ô ÀÌ½ÄÆíÀ» ¼³°èÇÒ ¼ö ÀÖ´Â µ¶º¸ÀûÀÎ Á¤È®¼ºÀ» Á¦°øÇÔÀ¸·Î½á ½ÃÀå ¼ºÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀþÀº Ãþ¿¡¼­ ½ºÆ÷Ã÷¿Í Ȱµ¿ÀûÀÎ ¶óÀÌÇÁ½ºÅ¸ÀÏ¿¡ ´ëÇÑ Àνİú ÀαⰡ ³ô¾ÆÁö¸é¼­ ½ºÆ÷Ã÷ °ü·Ã ºÎ»ó, ƯÈ÷ ¹«¸­°ú ¾î±ú Àδ뿡 ¿µÇâÀ» ¹ÌÄ¡´Â ºÎ»óÀÇ ¹ß»ý·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó ³»±¸¼º°ú ź·ÂÀûÀÎ ÁöÁö·ÂÀ» Á¦°øÇÏ´Â Àΰø ÀÎ´ë ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°èÀûÀ¸·Î °í·ÉÈ­ »çȸ°¡ È®´ëµÊ¿¡ µû¶ó ³ëÀεéÀÇ ÅðÇ༺ °üÀý ÁúȯÀÌ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ħ½À¼ºÀÌ ³ôÀº »ý¹°ÇÐÀû À̽ļúº¸´Ù ÀΰøÀδ븦 ¼±ÅÃÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á±â±â ¾÷°è¿¡¼­´Â ºñ¿ë È¿À²ÀûÀÌ°í ±¤¹üÀ§ÇÏ°Ô »ç¿ëÇÒ ¼ö ÀÖ´Â ÀΰøÀÎ´ë °³¹ßÀ» À§ÇÑ ¿¬±¸°³¹ß ÅõÀÚ°¡ Ȱ¹ßÈ÷ ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀÌ ´Ù¾çÇÑ È¯ÀÚÃþ¿¡ Àû¿ëµÉ ¼ö ÀÖµµ·Ï ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½ÀÀû ¼ö¼úÀ» Àå·ÁÇÏ´Â ÀÇ·á Á¤Ã¥µµ º´¿ø°ú Ŭ¸®´Ð¿¡¼­ÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, ´Ü±â ¹× Àå±âÀûÀÎ °á°ú¸¦ °³¼±ÇÏ´Â Áö¼Ó°¡´ÉÇÑ »ýüÈí¼ö¼º Àç·á¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£µµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ÀÇ·á ºÐ¾ß¿¡¼­ ȯ°æ ģȭÀûÀÎ ¼±ÅÃÀ» Ãß±¸ÇÏ´Â ±¤¹üÀ§ÇÑ Ãß¼¼¸¦ ¹Ý¿µÇϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ´Ù°¢ÀûÀÎ »ê¾÷ ¿ªÇÐÀÌ ±â¼ú ¹ßÀü ¹× ȯÀÚ ¼±È£µµÀÇ ¹ßÀü°ú ¸Â¹°·Á ½ÃÀå ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­½Ã۰í ÀÖ½À´Ï´Ù.

ºÎ¹®

¿ëµµ(½½°üÀý ¼Õ»ó, ´Ù¸® °üÀý ¼Õ»ó, °ß°üÀý ¼Õ»ó, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø¡¤Å¬¸®´Ð, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Artificial Tendons and Ligaments Market to Reach US$75.1 Million by 2030

The global market for Artificial Tendons and Ligaments estimated at US$41.0 Million in the year 2024, is expected to reach US$75.1 Million by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Knee Injuries, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$35.2 Million by the end of the analysis period. Growth in the Foot & Ankle Injuries segment is estimated at 10.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$10.5 Million While China is Forecast to Grow at 14.1% CAGR

The Artificial Tendons and Ligaments market in the U.S. is estimated at US$10.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$17.4 Million by the year 2030 trailing a CAGR of 14.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 8.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

Global Artificial Tendons and Ligaments Market - Key Trends and Drivers Summarized

Are Artificial Tendons and Ligaments the Future of Orthopedic Medicine?

Artificial tendons and ligaments are transforming orthopedic medicine, promising groundbreaking advancements for those suffering from ligament injuries or degenerative conditions. Traditionally, damaged tendons and ligaments were treated through grafts sourced from the patient’s own body or from donors, a practice that presents challenges such as high variability in outcomes, potential immune reactions, and lengthy recovery times. The introduction of synthetic tendons and ligaments provides a reliable alternative that reduces reliance on donor tissues and minimizes complications associated with biological grafts. Made from biocompatible materials like polyethylene terephthalate (PET), polylactic acid (PLA), and polyurethane, artificial tendons and ligaments can be designed to emulate the natural properties of human tissue. These materials offer customization to match patient anatomy precisely, significantly lowering risks of rejection and improving long-term performance. As more orthopedic professionals recognize the value of synthetic alternatives, artificial tendons and ligaments are increasingly accepted in clinical applications for their resilience, durability, and tensile strength. The evolution of these artificial structures is addressing both sports injuries and degenerative joint conditions, positioning them as a highly promising option in advanced orthopedic care.

How Are Technological Advances Shaping the Development of Artificial Tendons and Ligaments?

Technological advances are profoundly shaping the field of artificial tendon and ligament development, leading to innovations that enhance both the physical characteristics and functional efficiency of these synthetic solutions. With advancements in material science, artificial tendons and ligaments are now crafted to closely mimic the structural and mechanical properties of natural tissues, allowing for a seamless fit within the human body. Research has introduced new materials, such as polyurethane composites and aramid fibers, which enhance durability and flexibility, providing patients with synthetic replacements that withstand substantial biomechanical stresses over time. Moreover, 3D printing technology has revolutionized the production process by enabling the creation of patient-specific grafts tailored to match each individual's unique anatomy, thereby optimizing their fit and adaptability to natural joint movements. Another technological leap has come from the field of nanotechnology, which is enhancing the cellular interactions and surface characteristics of these synthetic ligaments. Nanotech-enhanced surfaces encourage natural tissue integration while also reducing inflammation risks. Additionally, biodegradable and bioresorbable materials are entering the market, offering solutions that dissolve naturally over time, eliminating the need for further surgical removal and providing a sustainable approach to long-term healing.

Why Are Artificial Tendons and Ligaments Becoming More Popular Among Patients and Surgeons?

Artificial tendons and ligaments are gaining popularity among patients and surgeons alike due to the rapid recovery times, reduced complication rates, and less invasive nature of synthetic solutions compared to traditional biological grafts. For patients, especially athletes and individuals with active lifestyles, synthetic options offer a faster route to recovery, as these artificial solutions eliminate the need for secondary surgeries to harvest donor tissues from other parts of the body, which is often associated with additional morbidity. Individuals suffering from ligament injuries such as ACL or MCL tears, common in sports, are increasingly choosing synthetic replacements due to these enhanced benefits. Similarly, artificial tendons and ligaments are becoming popular among the elderly population, who often experience joint degeneration and seek alternatives to complex and prolonged biological grafting procedures. From the perspective of surgeons, synthetic options simplify the procedure, as they reduce the time and complexity of surgery, resulting in shorter operating times and reduced hospitalization periods, leading to cost-effectiveness and faster patient rehabilitation. Artificial tendons and ligaments also lower the likelihood of immune reactions, a common concern with biological grafts, and help avoid the need for multiple surgical sites, aligning well with the growing preference for minimally invasive treatments that minimize risk and maximize patient comfort.

What Factors Are Fueling the Growth of the Artificial Tendons and Ligaments Market?

The growth in the artificial tendons and ligaments market is driven by several factors, including advancements in technology, evolving end-use applications, and shifts in patient behavior and expectations. Technological innovations are significantly influencing market growth as the incorporation of AI and machine learning now enables the design of grafts with unparalleled precision, tailored to the unique anatomy and biomechanics of each patient. The rising awareness and popularity of sports and active lifestyles among younger populations are contributing to increased incidences of sports-related injuries, especially those affecting the knee and shoulder ligaments, which, in turn, is spurring demand for artificial ligament solutions that offer durable, resilient support. Furthermore, the aging population is expanding globally, leading to a surge in degenerative joint conditions among the elderly, who often opt for synthetic alternatives over more invasive biological grafting procedures. In addition, the medical device industry is experiencing substantial R&D investments aimed at developing cost-effective, widely accessible artificial ligament options, making these solutions more available to diverse patient demographics. Healthcare policies promoting minimally invasive surgeries are also driving adoption in hospitals and clinics, as synthetic grafts are aligned with patient demands for quicker recovery times and less invasive treatment. Finally, increased consumer preference for sustainable, bio-resorbable materials that enhance both short- and long-term outcomes reflects a broader trend toward eco-conscious choices in healthcare, further accelerating market growth as these multifaceted industry dynamics align with technological advancements and evolving patient preferences.

SCOPE OF STUDY:

The report analyzes the Artificial Tendons and Ligaments market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Knee Injuries, Foot & Ankle Injuries, Shoulder Injuries, Other Applications); End-Use (Hospitals & Clinics, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â